Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-05-15

Clinical Trial Update: Evaluating the Safety and Pharmacokinetics of Raltegravir in Infants

View source ↗

Summary

Clinical trial evaluating safety and pharmacokinetics of raltegravir in infants has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Raltegravir (raltegravir)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Status: COMPLETED | Results posted: 2019-05-15